Anavex Life Sciences Corp. (AVXL)
5.01
+0.16
(+3.30%)
USD |
NASDAQ |
Jan 16, 16:00
5.04
+0.03
(+0.60%)
After-Hours: 20:00
Anavex Life Sciences Market Cap: 447.63M for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CorMedix, Inc. | 534.19M |
| Verastem, Inc. | 503.14M |
| Ocugen, Inc. | 527.82M |
| AnaptysBio, Inc. | 1.265B |
| Replimune Group, Inc. | 552.24M |
Market Cap Related Metrics
| PEG Ratio | -1.606 |
| Price to Book Value | 4.718 |
| Price | 5.01 |
| Earnings Yield | -10.86% |
| PEGY Ratio | -1.606 |